Goldman Sachs’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-130,339
Closed -$228K 6365
2025
Q1
$228K Sell
130,339
-82,040
-39% -$108K ﹤0.01% 5582
2024
Q4
$336K Buy
212,379
+33,374
+19% +$51.3K ﹤0.01% 5452
2024
Q3
$281K Buy
179,005
+40,540
+29% +$67.1K ﹤0.01% 5330
2024
Q2
$247K Sell
138,465
-88,954
-39% -$206K ﹤0.01% 5181
2024
Q1
$655K Buy
+227,419
New +$371K ﹤0.01% 4598
2021
Q2
Sell
-1,805
Closed -$28K 6471
2021
Q1
$28K Sell
1,805
-3,829
-68% -$56.7K ﹤0.01% 5992
2020
Q4
$76K Buy
+5,634
New +$41.4K ﹤0.01% 5331
2018
Q3
Sell
-139
Closed -$11K 5756
2018
Q2
$11K Buy
+139
New +$11.5K ﹤0.01% 5536
2017
Q3
Sell
-3,069
Closed -$363K 6821
2017
Q2
$363K Buy
3,069
+2,007
+189% +$335K ﹤0.01% 5349
2017
Q1
$210K Sell
1,062
-842
-44% -$160K ﹤0.01% 5706
2016
Q4
$514K Sell
1,904
-1,398
-42% -$454K ﹤0.01% 5041
2016
Q3
$1.31M Sell
3,302
-3,171
-49% -$1.3M ﹤0.01% 4169
2016
Q2
$2.25M Buy
6,473
+22
+0.3% +$15.8K ﹤0.01% 3523
2016
Q1
$5.36M Buy
6,451
+236
+4% +$188K ﹤0.01% 2671
2015
Q4
$6.5M Buy
6,215
+544
+10% +$545K ﹤0.01% 2594
2015
Q3
$4.45M Sell
5,671
-1,137
-17% -$1.17M ﹤0.01% 2983
2015
Q2
$8.95M Buy
6,808
+117
+2% +$189K ﹤0.01% 2426
2015
Q1
$13.6M Buy
6,691
+2,107
+46% +$4.58M 0.01% 2049
2014
Q4
$8.82M Sell
4,584
-1,764
-28% -$3.14M ﹤0.01% 2459
2014
Q3
$5.2M Sell
6,348
-245
-4% -$207K ﹤0.01% 2971
2014
Q2
$6.36M Buy
6,593
+56
+0.9% +$48K ﹤0.01% 2764
2014
Q1
$7.08M Sell
6,537
-1,323
-17% -$1.47M ﹤0.01% 2673
2013
Q4
$6.97M Buy
7,860
+652
+9% +$561K ﹤0.01% 2713
2013
Q3
$8.16M Buy
7,208
+1,982
+38% +$2.34M ﹤0.01% 2451
2013
Q2
$6.15M Buy
+5,226
New +$4.97M ﹤0.01% 2534

Other funds holding RGLS